Skip to content
About Us
Services & Solutions
News & Resources
Catalog Product
Careers
Contact Us
Start a project

Services & Solutions

Regulatory Dossier Preparation

Our global regulatory dossier preparation teams have extensive experience in global filings for IND, IMPD, and NDA submissions with the US FDA, EMA, and China’s NMPA. By integrating CMC…

740+

CMC submission packages written during 2019-2024

Our global regulatory dossier preparation teams have extensive experience in global filings for IND, IMPD, and NDA submissions with the US FDA, EMA, and China’s NMPA. By integrating CMC dossier preparation with our API and drug product development and manufacturing, we can expedite the timeline to IND and NDA. Typically, it takes our team 6-8 weeks to prepare an IND submission package for the US FDA.

TIDES CMC Dossier Preparation Experience

  • 20+ INDs for US FDA submission
  • 20+ INDs for China NMPA submission
Small Molecule
Oligonucleotide
Peptide

CMC Dossier Preparation Streamlined and Integrated as a Part of the Project Team

  • Project Initiation: provide RA consultation for phase and modality appropriate, country specific project scope and strategy
  • Project Execution: provide filing template, collect data once testing completed. Finish section writing along different phases and perform timely data review with clients to mitigate potential risks
  • Project Completion: complete submission-ready CMC dossiers

Why WuXi TIDES

What this platform adds

01

Scalability

From discovery to commercialisation entirely within WuXi TIDES, with readily available large R&D and manufacturing capacity.

02

Conjugation Chemistry

Seamless collaboration across the oligonucleotide, peptide and small molecule teams — the conjugates nobody else wants to touch.

03

New Technology

Biocatalysis for gRNA synthesis, thin film evaporation, reactor-in-series with PAT, continuous flow chromatography, TFF.

04

Global Quality Standard

One quality system across every site, approved by the major regulatory agencies around the world.

05

Comprehensive Analytical

Method development and validation, IPC and release testing, characterisation and stability under one roof.

06

Integrated CMC

API and formulation development, manufacturing, analytical, dossier preparation and clinical supply as a single programme.

Meeting global quality standards

Inspection record

0
US FDA
2013–2025
0
EU EMA
2009–2025
0
China NMPA
2015–2025
0
Japan PMDA
2019–2024
0
South Korea MFDS
2022
0
SwissMedic
2018–2025

How can we help?

Our TIDES drug experts stand ready.

Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.

Small molecule projects? WuXi STA